Literature DB >> 1574119

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

G Cammarota1, A Scheirle, B Takacs, D M Doran, R Knorr, W Bannwarth, J Guardiola, F Sinigaglia.   

Abstract

The CD4 and CD8 molecules are transmembrane glycoproteins expressed by functionally distinct subsets of mature T cells. CD4+ and CD8+ T cells recognize antigens on major histocompatibility complex (MHC) class II-bearing and class I-bearing target cells respectively. The ability of monoclonal antibodies against CD4 and CD8 to block antigen recognition by T cells, as well as cell-cell adhesion assays, indicate that CD4 and CD8 bind to nonpolymorphic determinants of class II or class I MHC. Here we demonstrate that soluble recombinant HLA-DR4 molecules from insect cells and HLA-DR-derived peptides bind to immobilized recombinant soluble CD4. CD4 binds recombinant soluble DR4 heterodimers, as well as the soluble DR4-beta chain alone. Furthermore, two out of twelve DR4-beta peptides could interact specifically with CD4. These findings show that CD4 interacts with a region of MHC class II molecules analogous to a previously identified loop in class I MHC proteins that binds CD8 (refs 8, 9).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574119     DOI: 10.1038/356799a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  58 in total

Review 1.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells.

Authors:  Bruce M Hall
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

3.  Characterization of MHC class II genes from an ancient reptile lineage, Sphenodon (tuatara).

Authors:  Hilary C Miller; Katherine Belov; Charles H Daugherty
Journal:  Immunogenetics       Date:  2005-10-29       Impact factor: 2.846

Review 4.  Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.

Authors:  Gregory G Burrows
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-04

5.  The immune function of MHC class II molecules mutated in the putative superdimer interface.

Authors:  John D Hayball; Richard A Lake
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

6.  The T cell receptor's alpha-chain connecting peptide motif promotes close approximation of the CD8 coreceptor allowing efficient signal initiation.

Authors:  Michel Mallaun; Dieter Naeher; Mark A Daniels; Pia P Yachi; Barbara Hausmann; Immanuel F Luescher; Nicholas R J Gascoigne; Ed Palmer
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

Review 7.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

8.  Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.

Authors:  S Bavari; R G Ulrich
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Identification of three distinct allelic forms of bovine CD4.

Authors:  W I Morrison; C J Howard; C J Hinson; N D MacHugh; P Sopp
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 10.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.